RNLX headed in the right direction. New partnership with Davita (S&P 500 company). JP Morgan Health Conference presenter on the 13th. And they still have the game changing antibody test kit with FDA EUA, and Europe CE mark.
Good luck.
Recent RNLX News
- Renalytix Reports Full Year Fiscal 2023 Results • GlobeNewswire Inc. • 09/28/2023 11:00:49 AM
- Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28 • GlobeNewswire Inc. • 09/25/2023 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:04:50 PM
- Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer • GlobeNewswire Inc. • 09/07/2023 11:00:27 AM
- Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd • GlobeNewswire Inc. • 08/03/2023 11:00:29 AM
- Renalytix Announces Middle East Distribution Agreement with Vector Pharma • GlobeNewswire Inc. • 07/21/2023 11:00:08 AM
- Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions • GlobeNewswire Inc. • 07/07/2023 11:00:47 AM
- Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors • GlobeNewswire Inc. • 07/03/2023 11:00:00 AM
- Renalytix Gets FDA De Novo Marketing Authorization for KidneyIntelX.dkd • Dow Jones News • 06/29/2023 10:58:00 PM
- FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease • GlobeNewswire Inc. • 06/29/2023 10:01:17 PM
- KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences • GlobeNewswire Inc. • 06/15/2023 11:00:00 AM
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023 • GlobeNewswire Inc. • 06/09/2023 11:00:53 AM
- Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9 • GlobeNewswire Inc. • 06/05/2023 11:00:10 AM
- Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes • GlobeNewswire Inc. • 05/25/2023 11:00:00 AM
- New Published Real-World Evidence Shows KidneyIntelX™ Utility • GlobeNewswire Inc. • 04/19/2023 11:00:28 AM
- Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting • GlobeNewswire Inc. • 04/12/2023 11:00:26 AM
- Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/30/2023 11:00:15 AM
- Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30 • GlobeNewswire Inc. • 03/22/2023 11:00:27 AM
- Renalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelX • Dow Jones News • 03/21/2023 09:18:00 AM
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 02/09/2023 12:00:12 PM
- Renalytix announces a c.$20.3 million private placement • GlobeNewswire Inc. • 02/08/2023 12:00:49 PM
- Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States • GlobeNewswire Inc. • 01/26/2023 12:00:00 PM
- Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems • GlobeNewswire Inc. • 01/09/2023 12:00:00 PM
- BTIG Remains a Buy on Renalytix AI (RNLX) • TipRanks • 12/03/2022 03:05:22 AM
- H.C. Wainwright Sticks to Their Buy Rating for Renalytix AI (RNLX) • TipRanks • 12/02/2022 05:05:08 PM
FEATURED Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • Oct 3, 2023 8:50 AM
Strategic Joint Venture Signed by Santo Mining Corp. and Planta Vida S.A.S. • SANP • Oct 3, 2023 3:00 PM
Good Gaming, Inc. Announces Galactic Acres™ as Its First Mobile Game Integrated with Web3 Technology • GMER • Oct 3, 2023 8:30 AM
HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • HLYK • Oct 3, 2023 8:00 AM
Nate's Food Co Successfully Completes Cancellation of 1 Billion Common Shares, Paving the Way for a Bright Future • NHMD • Oct 3, 2023 8:00 AM
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • BLEG • Oct 3, 2023 8:00 AM